Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis. J of Skin [Internet]. 2022 Nov. 16 [cited 2026 Apr. 18];6(6):s52. Available from: https://skin.dermsquared.com/skin/article/view/1807